Search
for
Sort by
Research 811–840 of 1000+
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Comparison of Endocrine and Metabolic Profile of Obese and Lean PCOS Women with Infertility
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Metabolic effects of 5α-reductase inhibition in humans
- Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- Integrated Multi-Omics Analysis Reveals Dysregulated Lipid Metabolism as a Novel Mechanism in Androgenetic Alopecia
- 896 Androgens activate lipogenesis through an AKT-independent mTOR pathway stimulation and a limitation of autophagy in an androgen-sensitive sebocyte cell line
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Alopecia and Hirsuties
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Endocrine evaluation of hirsutism
- Pharmacology of Anti-androgens in the Skin
- The Predictive Value of Clinical Hirsutism for Biochemical Hyperandrogenism in a Large Endocrine Referral Cohort
- Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early‐Onset Androgenetic Alopecia: A Case–Control Study
- The association between androgenic alopecia severity and the development of metabolic syndrome in Saudi Arabia: A case-control study